Free for academic non-profit institutions. Other users need a Commercial license
DGCR5 (DiGeorge Syndrome Critical Region Gene 5) is an RNA Gene, and is affiliated with the lncRNA class. Diseases associated with DGCR5 include Hyperprolinemia, Type I and Hyperprolinemia.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH22J018967 | Enhancer | 0.5 | ENCODE | 250.7 | -1.1 | -1080 | 0.2 | ZIC2 CEBPB MAX USF2 ATF4 RNF2 ZSCAN29 | DGCR5 HSALNG0133980 PRODH FAM246C | |
GH22J018969 | Enhancer | 0.3 | CraniofacialAtlas | 250.7 | +0.8 | 785 | 0.4 | KLF1 GLIS2 | DGCR5 ENSG00000273032 PRODH DGCR6 FAM246C | |
GH22J018966 | Enhancer | 0.2 | FANTOM5 | 250.7 | -1.9 | -1937 | 0.3 | DGCR5 HSALNG0133980 PRODH FAM246C | ||
GH22J019477 | Promoter/Enhancer | 2.2 | EPDnew Ensembl ENCODE CraniofacialAtlas dbSUPER | 11.6 | +510.4 | 510397 | 4.2 | CHD2 ZBTB10 SP1 MXD4 FEZF1 SIX5 NR2C1 MNT IKZF1 ETS1 | UFD1 CDC45 DGCR8 TRMT2A RPL7AP70 DGCR11 LINC01311 RANBP1 ENSG00000273300 ENSG00000215493 | |
GH22J019446 | Promoter/Enhancer | 2.2 | EPDnew Ensembl ENCODE CraniofacialAtlas | 11.6 | +478.8 | 478798 | 3.4 | MXD4 SP1 FEZF1 NR2C1 MNT IKZF1 SMAD5 MBD2 POLR2A ZBTB7B | C22orf39 ENSG00000185065 HIRA LOC105372860 DGCR8 TRMT2A UFD1 LINC01311 RPL8P5 RPL7AP70 |
RNAcentral Transcript ID | Subcategory | Length (nts) | # of Sources | Source Identifiers and Annotations |
---|---|---|---|---|
URS00009BFB8D_9606 | lncRNA | 1326 | 2 |
RefSeq: NR_110533, NONCODE: NONHSAT191992.1, |
URS0000BC43E4_9606 | lncRNA | 3323 | 1 |
RefSeq: NR_002733, |
URS0000BC43F2_9606 | lncRNA | 3179 | 1 |
RefSeq: NR_045121, |
URS0000759BEC_9606 | lncRNA | 2415 | 1 |
RefSeq: NR_024159, |
URS000075DFDD_9606 | lncRNA | 927 | 1 |
RefSeq: NR_026651, |
Disorder | Aliases | PubMed IDs |
---|---|---|
hyperprolinemia, type i |
|
|
hyperprolinemia |
|
|
digeorge syndrome |
|
|
velocardiofacial syndrome |
|
|
lung cancer susceptibility 3 |
|